News
42m
India Today on MSNWeight-loss and new-age drugs: Dr Ambrish Mithal on Wegovy's India debutWith the weight-loss blockbuster drug Wegovy, now in India, renowned endocrinologist and diabetologist Dr. Ambrish Mithal ...
Boots Online Doctor has revealed the 'very common' side-effects of Mounjaro you need to know about after thousands of people ...
4h
The Scarborough News on MSNWeight loss drug 'not available from local GP surgeries or pharmacies'Prescriptions for tirzepatide injections will not be available from GP surgeries or pharmacies in East and North Yorkshire – ...
Novo Nordisk launches Wegovy in India, expanding GLP-1 obesity drug market. The product competes with Eli Lilly's Mounjaro ...
Xu and her team also next plan to study whether tirzepatide and other emerging, potentially more effective GLP-1 drugs can provide an even greater buffer against dementia.
In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...
21m
nottinghamworld.com on MSNWeight-loss injections could be available on the NHS for those with highest clinical needThese injections are part of a wider NHS approach to help people manage their weight and improve their health. They are not a ...
Scholar Rock's Apitegromab excels in Phase 2 trials, aiding muscle preservation with Tirzepatide. Click here to read why I ...
Eli Lilly's bimagrumab led to weight loss that was due almost entirely to fat reduction when combined with semaglutide, ...
Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply, and believes ...
In a Phase II trial, Amgen’s investigational therapy MariTide (maridebart cafraglutide) delivered significant, sustained ...
BrightGene Pharmaceutical has scored an early win in its push to topple the big beasts of the GLP-1 field. | BrightGene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results